During the past decade, Corporacio Sanitaria Parc Tauli de Sabadell, Servicio de Reumatologia conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Corporacio Sanitaria Parc Tauli de Sabadell, Servicio de Reumatologia" are "Arthritis" (1 trials), "Osteoarthritis" (1 trials) and "Postmenopausal Osteoporosis" (1 trials). Many other conditions were trialed in "Corporacio Sanitaria Parc Tauli de Sabadell, Servicio de Reumatologia" in a lesser frequency.

Most popular intervention types in "Corporacio Sanitaria Parc Tauli de Sabadell, Servicio de Reumatologia" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "NSAID" (1 trials), "Prolia®" (1 trials), "RGB-14-P" (1 trials) and "tanezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Corporacio Sanitaria Parc Tauli de Sabadell, Servicio de Reumatologia" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Corporacio Sanitaria Parc Tauli de Sabadell, Servicio de Reumatologia". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Corporacio Sanitaria Parc Tauli de Sabadell, Servicio de Reumatologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Corporacio Sanitaria Parc Tauli de Sabadell, Servicio de Reumatologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".